201 related articles for article (PubMed ID: 37206027)
1. A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia.
Partridge S; Quadt L; Bolton M; Eccles J; Thompson C; Colasanti A; Bremner S; Jones CI; Bruun KD; Van Marwijk H
Heliyon; 2023 May; 9(5):e15638. PubMed ID: 37206027
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.
Bruun KD; Amris K; Vaegter HB; Blichfeldt-Eckhardt MR; Holsgaard-Larsen A; Christensen R; Toft P
Trials; 2021 Nov; 22(1):804. PubMed ID: 34781989
[TBL] [Abstract][Full Text] [Related]
4. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
5. Low dose naltrexone for induction of remission in Crohn's disease.
Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
[TBL] [Abstract][Full Text] [Related]
6. Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial.
Paula TMH; Castro MS; Medeiros LF; Paludo RH; Couto FF; Costa TRD; Fortes JP; Salbego MO; Behnck GS; Moura TAM; Tarouco ML; Caumo W; Souza A
Braz J Anesthesiol; 2023; 73(4):409-417. PubMed ID: 35988815
[TBL] [Abstract][Full Text] [Related]
7. The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review.
Yang J; Shin KM; Do A; Bierle DM; Abu Dabrh AM; Yin Z; Bauer BA; Mohabbat AB
J Pain Res; 2023; 16():1017-1023. PubMed ID: 36974308
[TBL] [Abstract][Full Text] [Related]
8. Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study).
Colomer-Carbonell A; Sanabria-Mazo JP; Hernández-Negrín H; Borràs X; Suso-Ribera C; García-Palacios A; Muchart J; Munuera J; D'Amico F; Maes M; Younger JW; Feliu-Soler A; Rozadilla-Sacanell A; Luciano JV
BMJ Open; 2022 Jan; 12(1):e055351. PubMed ID: 34992118
[TBL] [Abstract][Full Text] [Related]
9. Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study.
Bested K; Jensen LM; Andresen T; Tarp G; Skovbjerg L; Johansen TSD; Schmedes AV; Storgaard IK; Madsen JS; Werner MU; Bendiksen A
Pain Rep; 2023; 8(4):e1080. PubMed ID: 38226027
[TBL] [Abstract][Full Text] [Related]
10. Aquatic exercise training for fibromyalgia.
Bidonde J; Busch AJ; Webber SC; Schachter CL; Danyliw A; Overend TJ; Richards RS; Rader T
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011336. PubMed ID: 25350761
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis.
Driver CN; D'Souza RS
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189705
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotics for fibromyalgia in adults.
Walitt B; Klose P; Üçeyler N; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011804. PubMed ID: 27251337
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin for pain in fibromyalgia in adults.
Derry S; Cording M; Wiffen PJ; Law S; Phillips T; Moore RA
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011790. PubMed ID: 27684492
[TBL] [Abstract][Full Text] [Related]
14. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Younger J; Parkitny L; McLain D
Clin Rheumatol; 2014 Apr; 33(4):451-9. PubMed ID: 24526250
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine for fibromyalgia in adults.
Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids for fibromyalgia.
Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
[TBL] [Abstract][Full Text] [Related]
17. Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review.
Rupp A; Young E; Chadwick AL
Pain Med; 2023 Nov; 24(11):1270-1281. PubMed ID: 37302106
[TBL] [Abstract][Full Text] [Related]
18. Aerobic exercise training for adults with fibromyalgia.
Bidonde J; Busch AJ; Schachter CL; Overend TJ; Kim SY; Góes SM; Boden C; Foulds HJ
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012700. PubMed ID: 28636204
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.
Johnson MI; Claydon LS; Herbison GP; Jones G; Paley CA
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012172. PubMed ID: 28990665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
